Bayview Legacy, LLC 4

What Happened
Bayview Legacy, LLC (a reported 10% owner of Arteris, Inc.; managed by K. Charles Janac) sold a total of 192,686 Arteris (AIP) shares in multiple open‑market transactions on July 2, 2026. The eight reported lots had weighted‑average prices and proceeds as follows:

• 11,000 shares @ $37.61 = $413,681
• 39,880 shares @ $36.70 = $1,463,440
• 26,348 shares @ $35.67 = $939,894
• 80,042 shares @ $34.77 = $2,783,108
• 24,691 shares @ $38.89 = $960,211
• 5,482 shares @ $39.72 = $217,765
• 2,500 shares @ $40.78 = $101,958
• 2,743 shares @ $43.24 = $118,596

Aggregate proceeds were about $6.999 million. These were sales (not purchases); sales are often routine portfolio/liquidity actions rather than a direct signal about company prospects.

Key Details

• Transaction date: July 2, 2026 (filed on Form 4 July 6, 2026 — appears to be timely within the usual 2 business‑day window).
• Price information: reported as weighted average prices for each lot; underlying trade price ranges across lots span roughly $34.20 to $43.51 per share (see footnotes for per‑lot ranges).
• Shares owned after transaction: not provided in the summary data supplied.
• Footnotes: Transactions were made pursuant to a 10b5‑1 trading plan adopted December 12, 2025 (footnote F1). K. Charles Janac, as manager of Bayview Legacy, is deemed to have voting and dispositive power and filed a separate Form 4 for the same activity (footnotes F2, F4). Several footnotes note that reported prices are weighted averages and provide the ranges for the multiple trades in each lot (F3–F11).
• Transaction code: S = Sale.

Context

• This filing reflects activity by a 10% owner (an affiliated institutional holder), not necessarily an operational executive — although the manager (K. Charles Janac) has control and filed separately. Institutional sales like this can be for diversification, liquidity, or plan‑driven reasons (here, a 10b5‑1 plan), so they are not definitive indicators of company performance.
• For retail investors: purchases by insiders tend to be more informative about insider confidence; significant, plan‑driven sales should be noted but interpreted cautiously.